Home > Browse Research > Life Sciences > Biotechnology > Personalized Medicine

Personalized Medicine: market research reports

Personalized Medicine market research reports and industry analysis

Personalized Medicine & Orphan Drugs Review and Outlook 2010 8/1/2010 \| published by: PharmaLive Special Reports ... "medicine." Advancements in science and diagnostic technology are required to reach this standard of care. In addition, health agencies need to establish clear regulatory frameworks for this complicated field, insurers must allow for adequate reimbursement, ... \| read more...	$455.00
The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine 6/23/2010 \| published by: Business Insights ... Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately ... \| read more...	$3,835.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies 5/1/2010 \| published by: Arrowhead Publishers ... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ... \| read more...	$2,495.00
Combination Drug/Diagnostic Products and Other Applications of Personalized Medicine-Strategic Issues Facing Companies in this Market 4/1/2010 \| published by: CHI Insight Pharma Reports ... Personalized medicine has emerged as an important field for companies in both the pharmaceutical and the diagnostic industries. While many drugs in development and on the market today still follow the traditional approach where drugs ... \| read more...	$2,995.00
Combination Drug Diagnostics: Fueling Growth of Personalized Medicine Report 4/1/2010 \| published by: CHI Insight Pharma Reports ... combinations Emerging new applications Strategic options for pharmaceutical and diagnostic companies Regulatory and reimbursement issues Physician education and acceptable hurdles Interviews with experts Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine examines the role of Rx/Dx ... \| read more...	$3,750.00
Personalized Medicine Market Worldwide (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast 2/14/2010 \| published by: Renub Research ... from past trends to future scenario (2006 to 2015). Personalized medicine segments like Genetically Modified (GM) Products, Wellness & Disease Management, Targeted Biologics, Other Molecular Diagnostics, Genomics and Proteomics and Consumer Self Diagnostic markets data ... \| read more...	$1,100.00
SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine 2/1/2010 \| published by: Kalorama Information ... exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and ... \| read more...	$1,995.00
Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine 12/17/2009 \| published by: Datamonitor ... be able to predict response to expensive biologic therapies and match specific treatments to patients based upon biomarker profiles. Scope Classification and overview of biomarkers used in routine clinical practice across five rheumatology indications. Identification ... \| read more...	$3,800.00
Business Strategy: Personalized Medicine Looking Forward 12/13/2009 \| published by: IDC ... key signposts of progress, market drivers impacting the segment, and both near- and long-term market opportunities for the segment. As we continue to hear more and more about broad efforts to transform the health industry ... \| read more...	$4,500.00
Regulatory and Legislative Activities: Shaping Biomarker and Diagnostic Use and Driving Personalized Medicine 11/13/2009 \| published by: Decision Resources ... to the industry by publishing guidance and requesting commentary. Additionally, recent legislation, such as GINA, is giving companies new opportunities to further their efforts in personalized medicine. However, plenty of barriers still exist: some are ... \| read more...	$4,600.00
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine 10/21/2009 \| published by: Datamonitor ... Currently, there are 77 agents in development for CRC, 4 of which are in late-phase development. Collectively, they are forecast to achieve sales of $1,398m by 2018. Scope Examination of the CRC pipeline with in-depth ... \| read more...	$11,400.00
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach 8/1/2009 \| published by: Business Insights ... of nutrition means that better nutritional care of patients is increasingly on the agenda of governments and healthcare professionals alike. Add to that the rise in diseases (often associated with aging populations) that can be ... \| read more...	$3,835.00
Personalized Medicine: Technologies and the Global Market 7/1/2009 \| published by: BCC Research ... for the worldwide market for personalized medicine Estimates the growth of all submarkets for personalized medicine in terms of technology, products, services, geography and applications areas Analyzes the current personalized medicine business model and looks ... \| read more...	$5,450.00
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine 4/17/2009 \| published by: Decision Resources ... used to discover new biomarkers and develop in vitro diagnostics. Companies large and small are recognizing the value of NAT, and both R&D and dealmaking activity is robust. Find out who the players are and ... \| read more...	$4,600.00
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players) 4/1/2009 \| published by: Kalorama Information ... personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this ... \| read more...	$995.00
Dealmaking and Business Strategies in the Age of Personalized Medicine 3/26/2009 \| published by: Decision Resources ... still worried. They do not understand how this area will play out and are risk-averse to working in the brave new world of RxDx regulation. In addition, the ability to mine large databases for clinical, ... \| read more...	$4,600.00
The Opportunity for the Obama Economic Stimulus Bill to Accelerate Personalized Medicine 3/2/2009 \| published by: IDC ... accelerate the broad adoption of personalized medicine (PM) in the United States. From the broad creation of electronic medical records (EMRs) to comparative effectiveness research to expanded National Institutes of Health (NIH) research, the economic ... \| read more...	$1,500.00
It’s All About the Biomarkers: How 2008’s Biomarker-Based Partnering Is Driving Personalized Medicine 12/17/2008 \| published by: Decision Resources ... Novel technologies, targeted therapies, companion diagnostics, validating biomarkers, standardizing processes, and the mere need for innovation are some of the factors that are compelling these stakeholders to collaborate. Biomarkers-characteristics that are objectively evaluated as indicators ... \| read more...	$4,600.00
Fulfilling the Promise of Personalized Medicine Through Next-Generation Sequencing 11/24/2008 \| published by: Decision Resources ... innovative drugs. However, the pharmaceutical industry will be expected to adapt to a more fl exible pricing environment. In this report, we analyze the potential impact of the changes unveiled in November 2008. Get the ... \| read more...	$4,600.00
How to Integrate Personalized Medicine into Business Strategies 9/24/2008 \| published by: Decision Resources ... to integrate a personalized medicine approach into business strategies? We provide perspectives from pharmaceutical, diagnostic, and managed care executives and create a set of recommendations based on what experts advise when contemplating the operational shift ... \| read more...	$4,600.00
Thinking Forward: A Revolutionary Model That Delivers Value and Market Opportunity for Personalized Medicines 7/11/2008 \| published by: IDC ... the need to reimburse PM-based diagnostic testing based on the value it delivers. This expectation directly conflicts with current cost-based diagnostics reimbursement practices put in place in the 1980s and is partly responsible for the ... \| read more...	$1,500.00
Cancer Personalized Medicine 2008 7/1/2008 \| published by: Select Biosciences Limited ... Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses in on the science, market/commercialization, and diagnostic/therapeutics trends in this space. The Cancer Personalized Medicine marketplace represents the paradigm ... \| read more...	$4,860.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine) 6/1/2008 \| published by: Kalorama Information ... the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as ... \| read more...	$2,995.00
Payers on the Future of Personalized Medicine, Part 1: Getting Ready for Change 4/10/2008 \| published by: IDC ... of the concept of personalized medicine across the entire health industry value chain, personalized health impacts all market segments, including healthcare payers. Through their role in managing the financial component of healthcare delivery, payers are ... \| read more...	$4,500.00
Signs of Progress: Realizing the Vision and Path to Personalized Medicine 9/27/2007 \| published by: IDC This document is about Signs of Progress: Realizing the Vision and Path to Personalized Medicine \| read more...	$1,500.00

< prev 1 2 3 next >